covishield

NEW DELHI: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. This is for the first time that a booster…

Free COVID Booster Dose: People in the age group of 18 to 59 years can get a COVID booster dose for free. Aimed at boosting the uptake of Covid precaution doses, the new vaccine drive has been launched as part of the…

NEW DELHI: Seventy per cent of the people who received a booster dose of the Covid vaccine did not contract the disease during the third wave, according to a new study that covered around 6,000 people in India. The study led by Dr Rajeev…

New Delhi: A day before ‘precautionary’ COVID-19 vaccine doses would be made available to everyone above 18 years of age, the Central government on Saturday said private vaccination centres can charge only up to a maximum of…

New Delhi: Indian vaccine maker Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and…

New Delhi: Cyrus Poonawalla, Managing Director of the Serum Institute of India (SII), is the richest healthcare billionaire in the world, according to the 2022 M3M Hurun India Rich List. The ‘Vaccine King’ registered a…

AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time. The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at…

HYDERABAD: Mix-match of different Covid vaccines is safe and produces higher antibody response, according to a study released by AIG Hospitals here on Monday. The study, led by AIG Hospitals and researchers from the Asian Healthcare…

Geneva: A day after the European Commission authorised the use of the US-based Novavax Covid-19 vaccine, the World Health Organization (WHO) on Tuesday also approved ‘Nuvaxovid’ for emergency use, reported Agence France…

New Delhi: The Subject Expert Committee (SEC) of the Central government on Friday rejected the plea of Serum Institute of India for approval of Covishield as a booster dose, CNN-News18 reported. Earlier in the day, the…